Global and Japan Huntington's Disease Therapeutics Market Insights, Forecast to 2027

Publisher Name :
Date: 05-Oct-2021
No. of pages: 138
Inquire Before Buying

Huntington's Disease Therapeutics market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Huntington's Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For Japan market, this report focuses on the Huntington's Disease Therapeutics market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type

- Antidopaminergics

- Anticonvulsants

- Antipsychotics

- Antidepressants

Segment by Application

- Hospitals

- Clinics

- Diagnostic Centers

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- F. Hoffmann-La Roche

- H. Lundbeck

- Prana Biotechnology

- Teva Pharmaceutical Industries

- Horizon Pharma

Global and Japan Huntington's Disease Therapeutics Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Huntington's Disease Therapeutics Product Introduction
1.2 Market by Type
1.2.1 Global Huntington's Disease Therapeutics Market Size Growth Rate by Type
1.2.2 Antidopaminergics
1.2.3 Anticonvulsants
1.2.4 Antipsychotics
1.2.5 Antidepressants
1.3 Market by Application
1.3.1 Global Huntington's Disease Therapeutics Market Size Growth Rate by Application
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Huntington's Disease Therapeutics Market Size, Estimates and Forecasts
2.1.1 Global Huntington's Disease Therapeutics Revenue 2016-2027
2.1.2 Global Huntington's Disease Therapeutics Sales 2016-2027
2.2 Global Huntington's Disease Therapeutics, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Huntington's Disease Therapeutics Historical Market Size by Region (2016-2021)
2.3.1 Global Huntington's Disease Therapeutics Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Huntington's Disease Therapeutics Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Huntington's Disease Therapeutics Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Huntington's Disease Therapeutics Sales Forecast by Region (2022-2027)
2.4.2 Global Huntington's Disease Therapeutics Revenue Forecast by Region (2022-2027)
3 Global Huntington's Disease Therapeutics Competitor Landscape by Players
3.1 Global Top Huntington's Disease Therapeutics Manufacturers by Sales
3.1.1 Global Huntington's Disease Therapeutics Sales by Manufacturer (2016-2021)
3.1.2 Global Huntington's Disease Therapeutics Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Huntington's Disease Therapeutics Manufacturers by Revenue
3.2.1 Key Huntington's Disease Therapeutics Manufacturers Covered: Ranking by Revenue
3.2.2 Global Huntington's Disease Therapeutics Revenue by Manufacturers (2016-2021)
3.2.3 Global Huntington's Disease Therapeutics Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Huntington's Disease Therapeutics Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Huntington's Disease Therapeutics Revenue in 2020
3.2.6 Global Huntington's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Huntington's Disease Therapeutics Price by Manufacturers
3.4 Global Huntington's Disease Therapeutics Manufacturing Base Distribution, Product Types
3.4.1 Huntington's Disease Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Huntington's Disease Therapeutics Product Type
3.4.3 Date of International Manufacturers Enter into Huntington's Disease Therapeutics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Huntington's Disease Therapeutics Market Size by Type (2016-2021)
4.1.1 Global Huntington's Disease Therapeutics Sales by Type (2016-2021)
4.1.2 Global Huntington's Disease Therapeutics Revenue by Type (2016-2021)
4.1.3 Huntington's Disease Therapeutics Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Huntington's Disease Therapeutics Market Size Forecast by Type (2022-2027)
4.2.1 Global Huntington's Disease Therapeutics Sales Forecast by Type (2022-2027)
4.2.2 Global Huntington's Disease Therapeutics Revenue Forecast by Type (2022-2027)
4.2.3 Huntington's Disease Therapeutics Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Huntington's Disease Therapeutics Market Size by Application (2016-2021)
5.1.1 Global Huntington's Disease Therapeutics Sales by Application (2016-2021)
5.1.2 Global Huntington's Disease Therapeutics Revenue by Application (2016-2021)
5.1.3 Huntington's Disease Therapeutics Price by Application (2016-2021)
5.2 Huntington's Disease Therapeutics Market Size Forecast by Application (2022-2027)
5.2.1 Global Huntington's Disease Therapeutics Sales Forecast by Application (2022-2027)
5.2.2 Global Huntington's Disease Therapeutics Revenue Forecast by Application (2022-2027)
5.2.3 Global Huntington's Disease Therapeutics Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Huntington's Disease Therapeutics Market Size YoY Growth 2016-2027
6.1.1 Japan Huntington's Disease Therapeutics Sales YoY Growth 2016-2027
6.1.2 Japan Huntington's Disease Therapeutics Revenue YoY Growth 2016-2027
6.1.3 Japan Huntington's Disease Therapeutics Market Share in Global Market 2016-2027
6.2 Japan Huntington's Disease Therapeutics Market Size by Players (International and Local Players)
6.2.1 Japan Top Huntington's Disease Therapeutics Players by Sales (2016-2021)
6.2.2 Japan Top Huntington's Disease Therapeutics Players by Revenue (2016-2021)
6.3 Japan Huntington's Disease Therapeutics Historic Market Review by Type (2016-2021)
6.3.1 Japan Huntington's Disease Therapeutics Sales Market Share by Type (2016-2021)
6.3.2 Japan Huntington's Disease Therapeutics Revenue Market Share by Type (2016-2021)
6.3.3 Japan Huntington's Disease Therapeutics Price by Type (2016-2021)
6.4 Japan Huntington's Disease Therapeutics Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Huntington's Disease Therapeutics Sales Forecast by Type (2022-2027)
6.4.2 Japan Huntington's Disease Therapeutics Revenue Forecast by Type (2022-2027)
6.4.3 Japan Huntington's Disease Therapeutics Price Forecast by Type (2022-2027)
6.5 Japan Huntington's Disease Therapeutics Historic Market Review by Application (2016-2021)
6.5.1 Japan Huntington's Disease Therapeutics Sales Market Share by Application (2016-2021)
6.5.2 Japan Huntington's Disease Therapeutics Revenue Market Share by Application (2016-2021)
6.5.3 Japan Huntington's Disease Therapeutics Price by Application (2016-2021)
6.6 Japan Huntington's Disease Therapeutics Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Huntington's Disease Therapeutics Sales Forecast by Application (2022-2027)
6.6.2 Japan Huntington's Disease Therapeutics Revenue Forecast by Application (2022-2027)
6.6.3 Japan Huntington's Disease Therapeutics Price Forecast by Application (2022-2027)
7 North America
7.1 North America Huntington's Disease Therapeutics Market Size YoY Growth 2016-2027
7.2 North America Huntington's Disease Therapeutics Market Facts & Figures by Country
7.2.1 North America Huntington's Disease Therapeutics Sales by Country (2016-2021)
7.2.2 North America Huntington's Disease Therapeutics Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Huntington's Disease Therapeutics Market Size YoY Growth 2016-2027
8.2 Asia Pacific Huntington's Disease Therapeutics Market Facts & Figures by Region
8.2.1 Asia Pacific Huntington's Disease Therapeutics Sales by Region (2016-2021)
8.2.2 Asia Pacific Huntington's Disease Therapeutics Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Huntington's Disease Therapeutics Market Size YoY Growth 2016-2027
9.2 Europe Huntington's Disease Therapeutics Market Facts & Figures by Country
9.2.1 Europe Huntington's Disease Therapeutics Sales by Country (2016-2021)
9.2.2 Europe Huntington's Disease Therapeutics Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Huntington's Disease Therapeutics Market Size YoY Growth 2016-2027
10.2 Latin America Huntington's Disease Therapeutics Market Facts & Figures by Country
10.2.1 Latin America Huntington's Disease Therapeutics Sales by Country (2016-2021)
10.2.2 Latin America Huntington's Disease Therapeutics Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Huntington's Disease Therapeutics Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Huntington's Disease Therapeutics Market Facts & Figures by Country
11.2.1 Middle East and Africa Huntington's Disease Therapeutics Sales by Country (2016-2021)
11.2.2 Middle East and Africa Huntington's Disease Therapeutics Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 F. Hoffmann-La Roche
12.1.1 F. Hoffmann-La Roche Corporation Information
12.1.2 F. Hoffmann-La Roche Description and Business Overview
12.1.3 F. Hoffmann-La Roche Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.1.4 F. Hoffmann-La Roche Huntington's Disease Therapeutics Products Offered
12.1.5 F. Hoffmann-La Roche Recent Development
12.2 H. Lundbeck
12.2.1 H. Lundbeck Corporation Information
12.2.2 H. Lundbeck Description and Business Overview
12.2.3 H. Lundbeck Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.2.4 H. Lundbeck Huntington's Disease Therapeutics Products Offered
12.2.5 H. Lundbeck Recent Development
12.3 Prana Biotechnology
12.3.1 Prana Biotechnology Corporation Information
12.3.2 Prana Biotechnology Description and Business Overview
12.3.3 Prana Biotechnology Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Prana Biotechnology Huntington's Disease Therapeutics Products Offered
12.3.5 Prana Biotechnology Recent Development
12.4 Teva Pharmaceutical Industries
12.4.1 Teva Pharmaceutical Industries Corporation Information
12.4.2 Teva Pharmaceutical Industries Description and Business Overview
12.4.3 Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Teva Pharmaceutical Industries Huntington's Disease Therapeutics Products Offered
12.4.5 Teva Pharmaceutical Industries Recent Development
12.5 Horizon Pharma
12.5.1 Horizon Pharma Corporation Information
12.5.2 Horizon Pharma Description and Business Overview
12.5.3 Horizon Pharma Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Horizon Pharma Huntington's Disease Therapeutics Products Offered
12.5.5 Horizon Pharma Recent Development
12.11 F. Hoffmann-La Roche
12.11.1 F. Hoffmann-La Roche Corporation Information
12.11.2 F. Hoffmann-La Roche Description and Business Overview
12.11.3 F. Hoffmann-La Roche Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2016-2021)
12.11.4 F. Hoffmann-La Roche Huntington's Disease Therapeutics Products Offered
12.11.5 F. Hoffmann-La Roche Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Huntington's Disease Therapeutics Industry Trends
13.2 Huntington's Disease Therapeutics Market Drivers
13.3 Huntington's Disease Therapeutics Market Challenges
13.4 Huntington's Disease Therapeutics Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Huntington's Disease Therapeutics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Huntington's Disease Therapeutics Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Antidopaminergics
Table 3. Major Manufacturers of Anticonvulsants
Table 4. Major Manufacturers of Antipsychotics
Table 5. Major Manufacturers of Antidepressants
Table 6. Global Huntington's Disease Therapeutics Market Size Growth Rate by Application (2021-2027) & (K MT)
Table 7. Global Huntington's Disease Therapeutics Market Size by Region (K MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Huntington's Disease Therapeutics Sales by Regions (2016-2021) & (K MT)
Table 9. Global Huntington's Disease Therapeutics Sales Market Share by Regions (2016-2021)
Table 10. Global Huntington's Disease Therapeutics Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Huntington's Disease Therapeutics Sales Forecast by Region (2022-2027) & (K MT)
Table 12. Global Huntington's Disease Therapeutics Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Huntington's Disease Therapeutics Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Huntington's Disease Therapeutics Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Huntington's Disease Therapeutics Sales by Manufacturers (2016-2021) (K MT)
Table 16. Global Huntington's Disease Therapeutics Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Huntington's Disease Therapeutics Manufacturers by Revenue (US$ Million) in 2020
Table 18. Huntington's Disease Therapeutics Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Huntington's Disease Therapeutics Revenue Share by Manufacturers (2016-2021)
Table 20. Global Huntington's Disease Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Huntington's Disease Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Huntington's Disease Therapeutics as of 2020)
Table 22. Key Manufacturers Huntington's Disease Therapeutics Price (2016-2021) (USD/MT)
Table 23. Huntington's Disease Therapeutics Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Huntington's Disease Therapeutics Product Type
Table 25. Date of International Manufacturers Enter into Huntington's Disease Therapeutics Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Huntington's Disease Therapeutics Sales by Type (2016-2021) (K MT)
Table 28. Global Huntington's Disease Therapeutics Sales Share by Type (2016-2021)
Table 29. Global Huntington's Disease Therapeutics Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Huntington's Disease Therapeutics Revenue Share by Type (2016-2021)
Table 31. Huntington's Disease Therapeutics Average Selling Price (ASP) by Type (2016-2021) & (USD/MT)
Table 32. Global Huntington's Disease Therapeutics Sales Forecast by Type (2022-2027) & (K MT)
Table 33. Global Huntington's Disease Therapeutics Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Huntington's Disease Therapeutics Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Huntington's Disease Therapeutics Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Huntington's Disease Therapeutics Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT)
Table 37. Global Huntington's Disease Therapeutics Sales by Application (2016-2021) (K MT)
Table 38. Global Huntington's Disease Therapeutics Sales Share by Application (2016-2021)
Table 39. Global Huntington's Disease Therapeutics Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Huntington's Disease Therapeutics Revenue Share by Application (2016-2021)
Table 41. Huntington's Disease Therapeutics Average Selling Price (ASP) by Application (2016-2021) & (USD/MT)
Table 42. Global Huntington's Disease Therapeutics Sales Forecast by Application (2022-2027) & (K MT)
Table 43. Global Huntington's Disease Therapeutics Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Huntington's Disease Therapeutics Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Huntington's Disease Therapeutics Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Huntington's Disease Therapeutics Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT)
Table 47. Japan Huntington's Disease Therapeutics Sales (K MT) of Key Companies (2016-2021)
Table 48. Japan Huntington's Disease Therapeutics Sales Share by Company (2016-2021)
Table 49. Japan Huntington's Disease Therapeutics Revenue (US$ Million) by Company (2016-2021)
Table 50. Japan Huntington's Disease Therapeutics Revenue Share by Company (2016-2021)
Table 51. Japan Huntington's Disease Therapeutics Sales (K MT) by Type (2016-2021)
Table 52. Japan Huntington's Disease Therapeutics Sales Share by Type (2016-2021)
Table 53. Japan Huntington's Disease Therapeutics Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. Japan Huntington's Disease Therapeutics Price (USD/MT) by Type (2016-2021)
Table 55. Japan Huntington's Disease Therapeutics Sales (K MT) by Type (2022-2027)
Table 56. Japan Huntington's Disease Therapeutics Sales Share by Type (2022-2027)
Table 57. Japan Huntington's Disease Therapeutics Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. Japan Huntington's Disease Therapeutics Revenue Share by Type (2022-2027)
Table 59. Japan Huntington's Disease Therapeutics Price (USD/MT) by Type (2022-2027)
Table 60. Japan Huntington's Disease Therapeutics Sales (K MT) by Application (2016-2021)
Table 61. Japan Huntington's Disease Therapeutics Sales Share by Application (2016-2021)
Table 62. Japan Huntington's Disease Therapeutics Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. Japan Huntington's Disease Therapeutics Price (USD/MT) by Application (2016-2021)
Table 64. Japan Huntington's Disease Therapeutics Sales (K MT) by Application (2022-2027)
Table 65. Japan Huntington's Disease Therapeutics Sales Share by Application (2022-2027)
Table 66. Japan Huntington's Disease Therapeutics Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. Japan Huntington's Disease Therapeutics Revenue Share by Application (2022-2027)
Table 68. Japan Huntington's Disease Therapeutics Price (USD/MT) by Application (2022-2027)
Table 69. North America Huntington's Disease Therapeutics Sales by Country (2016-2021) & (K MT)
Table 70. North America Huntington's Disease Therapeutics Sales Market Share by Country (2016-2021)
Table 71. North America Huntington's Disease Therapeutics Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Huntington's Disease Therapeutics Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Huntington's Disease Therapeutics Sales by Region (2016-2021) & (K MT)
Table 74. Asia Pacific Huntington's Disease Therapeutics Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Huntington's Disease Therapeutics Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Huntington's Disease Therapeutics Revenue Market Share by Region (2016-2021)
Table 77. Europe Huntington's Disease Therapeutics Sales by Country (2016-2021) & (K MT)
Table 78. Europe Huntington's Disease Therapeutics Sales Market Share by Country (2016-2021)
Table 79. Europe Huntington's Disease Therapeutics Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Huntington's Disease Therapeutics Revenue Market Share by Country (2016-2021)
Table 81. Latin America Huntington's Disease Therapeutics Sales by Country (2016-2021) & (K MT)
Table 82. Latin America Huntington's Disease Therapeutics Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Huntington's Disease Therapeutics Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Huntington's Disease Therapeutics Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Huntington's Disease Therapeutics Sales by Country (2016-2021) & (K MT)
Table 86. Middle East and Africa Huntington's Disease Therapeutics Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Huntington's Disease Therapeutics Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Huntington's Disease Therapeutics Revenue Market Share by Country (2016-2021)
Table 89. F. Hoffmann-La Roche Corporation Information
Table 90. F. Hoffmann-La Roche Description and Business Overview
Table 91. F. Hoffmann-La Roche Huntington's Disease Therapeutics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 92. F. Hoffmann-La Roche Huntington's Disease Therapeutics Product
Table 93. F. Hoffmann-La Roche Recent Development
Table 94. H. Lundbeck Corporation Information
Table 95. H. Lundbeck Description and Business Overview
Table 96. H. Lundbeck Huntington's Disease Therapeutics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 97. H. Lundbeck Product
Table 98. H. Lundbeck Recent Development
Table 99. Prana Biotechnology Corporation Information
Table 100. Prana Biotechnology Description and Business Overview
Table 101. Prana Biotechnology Huntington's Disease Therapeutics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 102. Prana Biotechnology Product
Table 103. Prana Biotechnology Recent Development
Table 104. Teva Pharmaceutical Industries Corporation Information
Table 105. Teva Pharmaceutical Industries Description and Business Overview
Table 106. Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 107. Teva Pharmaceutical Industries Product
Table 108. Teva Pharmaceutical Industries Recent Development
Table 109. Horizon Pharma Corporation Information
Table 110. Horizon Pharma Description and Business Overview
Table 111. Horizon Pharma Huntington's Disease Therapeutics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 112. Horizon Pharma Product
Table 113. Horizon Pharma Recent Development
Table 114. Huntington's Disease Therapeutics Market Trends
Table 115. Huntington's Disease Therapeutics Market Drivers
Table 116. Huntington's Disease Therapeutics Market Challenges
Table 117. Huntington's Disease Therapeutics Market Restraints
Table 118. Huntington's Disease Therapeutics Customers List
Table 119. Huntington's Disease Therapeutics Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Huntington's Disease Therapeutics Product Picture
Figure 2. Global Huntington's Disease Therapeutics Sales Market Share by Type in 2020 & 2027
Figure 3. Antidopaminergics Product Picture
Figure 4. Anticonvulsants Product Picture
Figure 5. Antipsychotics Product Picture
Figure 6. Antidepressants Product Picture
Figure 7. Global Huntington's Disease Therapeutics Sales Market Share by Application in 2020 & 2027
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Diagnostic Centers
Figure 11. Huntington's Disease Therapeutics Report Years Considered
Figure 12. Global Huntington's Disease Therapeutics Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Huntington's Disease Therapeutics Market Size 2016-2027 (US$ Million)
Figure 14. Global Huntington's Disease Therapeutics Sales 2016-2027 (K MT)
Figure 15. Global Huntington's Disease Therapeutics Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Huntington's Disease Therapeutics Sales Market Share by Region (2016-2021)
Figure 17. Global Huntington's Disease Therapeutics Sales Market Share by Region in 2020
Figure 18. Global Huntington's Disease Therapeutics Revenue Market Share by Region (2016-2021)
Figure 19. Global Huntington's Disease Therapeutics Revenue Market Share by Region in 2020
Figure 20. Global Huntington's Disease Therapeutics Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Huntington's Disease Therapeutics Revenue in 2020
Figure 22. Huntington's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Huntington's Disease Therapeutics Sales Market Share by Type (2016-2021)
Figure 24. Global Huntington's Disease Therapeutics Sales Market Share by Type in 2020
Figure 25. Global Huntington's Disease Therapeutics Revenue Market Share by Type (2016-2021)
Figure 26. Global Huntington's Disease Therapeutics Revenue Market Share by Type in 2020
Figure 27. Global Huntington's Disease Therapeutics Sales Market Share by Application (2016-2021)
Figure 28. Global Huntington's Disease Therapeutics Sales Market Share by Application in 2020
Figure 29. Global Huntington's Disease Therapeutics Revenue Market Share by Application (2016-2021)
Figure 30. Global Huntington's Disease Therapeutics Revenue Market Share by Application in 2020
Figure 31. Japan Huntington's Disease Therapeutics Sales Growth Rate 2016-2027 (K MT)
Figure 32. Japan Huntington's Disease Therapeutics Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. Japan Huntington's Disease Therapeutics Market Share in Global Market 2016-2027
Figure 34. Japan 5 and 10 Largest Huntington's Disease Therapeutics Players Market Share by Revenue in Huntington's Disease Therapeutics in 2020
Figure 35. Japan Huntington's Disease Therapeutics Revenue Share by Type (2016-2021)
Figure 36. Japan Huntington's Disease Therapeutics Revenue Growth Rate by Type in 2016 & 2020
Figure 37. Japan Huntington's Disease Therapeutics Revenue Share by Application (2016-2021)
Figure 38. Japan Huntington's Disease Therapeutics Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Huntington's Disease Therapeutics Sales Growth Rate 2016-2021 (K MT)
Figure 40. North America Huntington's Disease Therapeutics Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America Huntington's Disease Therapeutics Sales Market Share by Country in 2020
Figure 42. North America Huntington's Disease Therapeutics Revenue Market Share by Country in 2020
Figure 43. U.S. Huntington's Disease Therapeutics Sales Growth Rate (2016-2021) (K MT)
Figure 44. U.S. Huntington's Disease Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada Huntington's Disease Therapeutics Sales Growth Rate (2016-2021) (K MT)
Figure 46. Canada Huntington's Disease Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Europe Huntington's Disease Therapeutics Sales Growth Rate 2016-2021 (K MT)
Figure 48. Europe Huntington's Disease Therapeutics Revenue Growth Rate 2016-2021 (US$ Million)
Figure 49. Europe Huntington's Disease Therapeutics Sales Market Share by Country in 2020
Figure 50. Europe Huntington's Disease Therapeutics Revenue Market Share by Country in 2020
Figure 51. Germany Huntington's Disease Therapeutics Sales Growth Rate (2016-2021) (K MT)
Figure 52. Germany Huntington's Disease Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. France Huntington's Disease Therapeutics Sales Growth Rate (2016-2021) (K MT)
Figure 54. France Huntington's Disease Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. U.K. Huntington's Disease Therapeutics Sales Growth Rate (2016-2021) (K MT)
Figure 56. U.K. Huntington's Disease Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Italy Huntington's Disease Therapeutics Sales Growth Rate (2016-2021) (K MT)
Figure 58. Italy Huntington's Disease Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Russia Huntington's Disease Therapeutics Sales Growth Rate (2016-2021) (K MT)
Figure 60. Russia Huntington's Disease Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Asia Pacific Huntington's Disease Therapeutics Sales Growth Rate 2016-2021 (K MT)
Figure 62. Asia Pacific Huntington's Disease Therapeutics Revenue Growth Rate 2016-2021 (US$ Million)
Figure 63. Asia Pacific Huntington's Disease Therapeutics Sales Market Share by Region in 2020
Figure 64. Asia Pacific Huntington's Disease Therapeutics Revenue Market Share by Region in 2020
Figure 65. China Huntington's Disease Therapeutics Sales Growth Rate (2016-2021) (K MT)
Figure 66. China Huntington's Disease Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Japan Huntington's Disease Therapeutics Sales Growth Rate (2016-2021) (K MT)
Figure 68. Japan Huntington's Disease Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. South Korea Huntington's Disease Therapeutics Sales Growth Rate (2016-2021) (K MT)
Figure 70. South Korea Huntington's Disease Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. India Huntington's Disease Therapeutics Sales Growth Rate (2016-2021) (K MT)
Figure 72. India Huntington's Disease Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Australia Huntington's Disease Therapeutics Sales Growth Rate (2016-2021) (K MT)
Figure 74. Australia Huntington's Disease Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Taiwan Huntington's Disease Therapeutics Sales Growth Rate (2016-2021) (K MT)
Figure 76. Taiwan Huntington's Disease Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Indonesia Huntington's Disease Therapeutics Sales Growth Rate (2016-2021) (K MT)
Figure 78. Indonesia Huntington's Disease Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Thailand Huntington's Disease Therapeutics Sales Growth Rate (2016-2021) (K MT)
Figure 80. Thailand Huntington's Disease Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Malaysia Huntington's Disease Therapeutics Sales Growth Rate (2016-2021) (K MT)
Figure 82. Malaysia Huntington's Disease Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Philippines Huntington's Disease Therapeutics Sales Growth Rate (2016-2021) (K MT)
Figure 84. Philippines Huntington's Disease Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Vietnam Huntington's Disease Therapeutics Sales Growth Rate (2016-2021) (K MT)
Figure 86. Vietnam Huntington's Disease Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Latin America Huntington's Disease Therapeutics Sales Growth Rate 2016-2021 (K MT)
Figure 88. Latin America Huntington's Disease Therapeutics Revenue Growth Rate 2016-2021 (US$ Million)
Figure 89. Latin America Huntington's Disease Therapeutics Sales Market Share by Country in 2020
Figure 90. Latin America Huntington's Disease Therapeutics Revenue Market Share by Country in 2020
Figure 91. Mexico Huntington's Disease Therapeutics Sales Growth Rate (2016-2021) (K MT)
Figure 92. Mexico Huntington's Disease Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Brazil
  • Global Huntington's Disease Therapeutics Market Insights, Forecast to 2029
    Published: 30-May-2023        Price: US 4900 Onwards        Pages: 94
    Huntington's disease is an inherited disease that causes degeneration of nerve cells in the central nervous system (CNS). The disease has a broad impact on functional abilities of the human and usually results in movement and thinking disabilities. Most people with Huntington's disease develop signs and symptoms in their age of 30 to 40. When disease begins before age 20, the condition is known as juvenile Huntington's disease. The global Huntington's Disease Therapeutics market is projec......
  • Global Huntington's Disease Therapeutics Professional Survey Report 2023, Forecast to 2028
    Published: 15-Mar-2023        Price: US 3280 Onwards        Pages: 105
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Huntington's Disease Therapeutics Market Research Report 2023, Forecast to 2028
    Published: 15-Mar-2023        Price: US 2680 Onwards        Pages: 133
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Huntington's Disease Therapeutics Market Research Report 2023
    Published: 07-Mar-2023        Price: US 2900 Onwards        Pages: 88
    Huntington's disease is an inherited disease that causes degeneration of nerve cells in the central nervous system (CNS). The disease has a broad impact on functional abilities of the human and usually results in movement and thinking disabilities. Most people with Huntington's disease develop signs and symptoms in their age of 30 to 40. When disease begins before age 20, the condition is known as juvenile Huntington's disease. Highlights The global Huntington's Disease Therapeutic......
  • Global Huntington's Disease Therapeutics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 16-Nov-2022        Price: US 5600 Onwards        Pages: 103
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Huntington's Disease Therapeutics manufacturers, distributors, end users, industry associations, governments' industry bure......
  • Global Huntington's Disease Therapeutics Market Research Report 2022
    Published: 13-Jul-2022        Price: US 2900 Onwards        Pages: 90
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type Antidopaminergics Anticonvulsants Antipsychotics Antidepressants Segment by Application......
  • Huntington's Disease Therapeutics Market - Global Outlook and Forecast 2021-2027
    Published: 02-Nov-2021        Price: US 3250 Onwards        Pages: 91
    This report contains market size and forecasts of Huntington's Disease Therapeutics in global, including the following market information: Global Huntington's Disease Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions) Global Huntington's Disease Therapeutics Market Sales, 2016-2021, 2022-2027, (K MT) Global top five Huntington's Disease Therapeutics companies in 2020 (%) The global Huntington's Disease Therapeutics market was valued at 233.9 million in 20......
  • Global and Japan Huntington's Disease Therapeutics Market Insights, Forecast to 2027
    Published: 05-Oct-2021        Price: US 3900 Onwards        Pages: 138
    Huntington's Disease Therapeutics market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Huntington's Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focu......
  • Global Huntington's Disease Therapeutics Market Research Report 2021
    Published: 11-Feb-2021        Price: US 2900 Onwards        Pages: 94
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Antidopaminergics - Anticonvulsants - Antipsychotics - Antidepressants Segment by App......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs